SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
2.195
+0.139 (6.79%)
At close: Aug 22, 2025, 4:00 PM
2.122
-0.073 (-3.32%)
After-hours: Aug 22, 2025, 7:40 PM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $22.85 million as of August 22, 2025. Its market cap has decreased by -6.76% in one year.
Market Cap
22.85M
Enterprise Value
23.55M
1-Year Change
-6.76%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $22.85M, a decrease of -82.53%. That is a compound annual growth rate of -31.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 22.85M | -34.76% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |